Format

Send to

Choose Destination
Cancers (Basel). 2019 Apr 24;11(4). pii: E582. doi: 10.3390/cancers11040582.

p53-Dependent Apoptotic Effect of Puromycin via Binding of Ribosomal Protein L5 and L11 to MDM2 and its Combination Effect with RITA or Doxorubicin.

Author information

1
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. johnsperfume@khu.ac.kr.
2
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. glansy555@gmail.com.
3
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. 964juha@daum.net.
4
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. simdy0821@naver.com.
5
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. hyojin1982@gmail.com.
6
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. bongleekim@khu.ac.kr.
7
Department of Biomedical Sciences, University of Ulsan, College of Medicine, Asan Medical Center, Seoul 05505, Korea. suhwan.chang@amc.seoul.kr.
8
College of Kyung Hee Medicine, Kyung Hee University, Seoul 02447, Korea. sungkim7@khu.ac.kr.

Abstract

Among ribosomal proteins essential for protein synthesis, the functions of ribosomal protein L5 (RPL5) and RPL11 still remain unclear to date. Here, the roles of RPL5 and RPL11 were investigated in association with p53/p21 signaling in the antitumor effect of puromycin mainly in HCT116 and H1299 cancer cells. Cell proliferation assays using 3-[4,5-dimethylthiazole-2-yl]-2,5-diphenyltetrazolium bromide (MTT) assays and colony formation assays, cell cycle analysis, Reverse transcription polymerase chain reaction (RT-PCR) and Western blotting were performed in cancer cells. Puromycin exerted cytotoxic and anti-proliferative effects in p53 wild-type HCT116 more than in p53 null H1299 cells. Consistently, puromycin increased sub-G1, cleaved Poly (ADP-ribose) polymerase (PARP), activated p53, p21, and Mouse double minute 2 homolog (MDM2), and attenuated expression of c-Myc in HCT116 cells. Notably, puromycin upregulated the expression of RPL5 and RPL11 to directly bind to MDM2 in HCT116 cells. Conversely, deletion of RPL5 and RPL11 blocked the activation of p53, p21, and MDM2 in HCT116 cells. Also, puromycin enhanced the antitumor effect with reactivating p53 and inducing tumor apoptosis (RITA) or doxorubicin in HCT116 cells. These findings suggest that puromycin induces p53-dependent apoptosis via upregulation of RPL5 or RPL11 for binding with MDM2, and so can be used more effectively in p53 wild-type cancers by combination with RITA or doxorubicin.

KEYWORDS:

Puromycin; RPL11; RPL5; doxorubicin; p53

Supplemental Content

Full text links

Icon for Multidisciplinary Digital Publishing Institute (MDPI) Icon for PubMed Central
Loading ...
Support Center